Skip to main content
. 2020 Oct 21;2020(10):CD013750. doi: 10.1002/14651858.CD013750

11.3. Analysis.

11.3

Comparison 11: Platinum vs non‐platinum regimens (sensitivity analysis 4: mTNBC patients selected for trial vs. a subgroup of trial), Outcome 3: Objective tumour response rate (assessable participants)